AFTER THIS FALL'S firestorm over the initial conflicts-of-interest document released with the ACCME's new Standards for Commercial Support, I have a deep appreciation for both the difficulties and the benefits of using faculty with ties to pharma. But what about those other conflicts of interest that don't often get talked about?

For example, I was speaking with a scientific affairs manager at a large pharma company who went into a bit of a rant about physicians who basically t

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.